VER Share PerformanceMore
|52 week high||53.350 31/03/16|
|52 week low||23.000 21/03/17|
|52 week change||-27.870 (-52.84%)|
|4 week volume||7,542,427 02/03/17|
Latest News« previous» nextMore
20/03/2017 - 11:30 StockMarketWire
N+1 Singer today reaffirms its hold investment rating on Vernalis PLC (LON:VER) and cut its price target to 28p (from 3...
06/03/2017 - 08:36 StockMarketWire
Vernalis and Servier have reinforced their partnership by entering into a new two-year oncology drug discovery collabora...
06/03/2017 - 08:00 RNS
Statement regarding an alliance between entities
28/02/2017 - 08:00 RNS
Notification of a change in the total number of voting rights
21/02/2017 - 08:00 RNS
Announcement of half-year/second quarter financial results
14/02/2017 - 12:10 StockMarketWire
Stifel today reaffirms its buy investment rating on Vernalis PLC (LON:VER) and set its price target at 104p.
14/02/2017 - 08:00 RNS
30/01/2017 - 14:03 StockMarketWire
Vernalis will announce its unaudited interim results for the six months ended 31 December on 21 February. At 1:03pm: (LO...
|Dividend yield||0 %|
Equity Research (VER)
Investment into addressing barriers to higher Tuzistra XR prescribing is starting to translate into higher prescription (Rx) rates. Mid-way through the second season post launch, both Rx and sales...
FDA acceptance of the CCP-08 NDA (setting a 4 August 2017 PDUFA date) advances Vernalis towards its goal of building a speciality US franchise of extended release (ER) prescription-only (Rx) cough...
Vernalis marked its transition into a commercial-stage speciality pharma company with the September 2015 US launch of Tuzistra XR, the first product from its extended release (ER) prescription only (...
- 1 of 4
Latest discussion posts More
“Just me and him then, anyone else? M”▼
“Wow these guys really believe this is a winner. Glad I bought in last week. M”▼
“Read Edison's note on VERNALIS, out this morning, by visiting https://www.research-tree.com/company/GB00B3Y5L754 "Vernalis intends to raise #40m (gross) through the issue of ...”▼
Codes & Symbols
|Symbols||VER, LSE:VER, VER.L, VER:LN, LON:VER, XLON:VER|